GlassScriptPhysician profile
Jeffrey S Rieder
NPI 1255397519
$14,137.92
in general payments reported to CMS, 2019-2025
49 companies · $2,718 in 2025
The $2,718 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,658 · 2020: $1,528 · 2021: $1,378 · 2022: $1,608 · 2023: $2,744 · 2024: $1,504 · 2025: $2,718.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,252 · Consulting Fee: $414 · Travel and Lodging: $287 · Education: $13.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,251.77 |
| Consulting Fee | $413.92 |
| Travel and Lodging | $286.98 |
| Education | $13.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $1,215.06 | 2019-2025 | Ffrct |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,071.18 | 2019-2025 | Lifevest |
| Amgen INC. | $988.77 | 2019-2025 | Repatha, Repatha |
| Abbott Laboratories | $956.62 | 2019-2025 | Amplatzer Amulet, Cardiomems, Jot Dx |
| Biotronik INC. | $910.19 | 2019-2025 | Selectra, Amvia Edge, Acticor 7 Vr-T Dx |
| Boston Scientific Corporation | $835.92 | 2019-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor, Resonate El Icd Vr |
| E.R. Squibb & Sons, L.L.C. | $791.29 | 2019-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $731.31 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $585.74 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $569.71 | 2019-2025 | Jardiance |
| Pfizer INC. | $543.63 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $506.91 | 2019-2024 | Wainua, Andexxa |
| Medtronic, INC. | $457.27 | 2021-2025 | Onyx Frontier, Tyrx, Mycarelink |
| Cms Imaging, INC. | $383.84 | 2021-2025 | |
| Actelion Pharmaceuticals US, INC. | $370.78 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $334.93 | 2022-2025 | Ambulatory Monitoring & Diagnostics Undivided, (5091) Amb Mon & Diag Und, (Ck4) Mcot |
| Novo Nordisk INC | $288.83 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $282.18 | 2021-2025 | Verquvo, Winrevair |
| Alnylam Pharmaceuticals INC. | $246.48 | 2019-2025 | Onpattro, Amvuttra |
| Sanofi-Aventis U.S. LLC | $238.88 | 2019-2023 | |
| Siemens Medical Solutions USA, INC. | $208.07 | 2025 | |
| Scpharmaceuticals INC. | $140.43 | 2023-2025 | |
| Kiniksa Pharmaceuticals, LTD. | $124.85 | 2021-2023 | Arcalyst |
| Regeneron Healthcare Solutions, INC. | $117.72 | 2019-2024 | Evkeeza, Praluent |
| Kiniksa Pharmaceuticals International, Plc | $106.64 | 2024 | Arcalyst |
| Medtronic Vascular, INC. | $106.12 | 2019-2020 | |
| Esperion Therapeutics, INC. | $104.20 | 2022-2025 | Nexletol |
| Amarin Pharma, INC. | $95.12 | 2019-2022 | |
| Astellas Pharma US INC | $86.57 | 2019-2020 | |
| Bridgebio Pharma, INC. | $68.33 | 2025 | Attruby |
| Atricure, INC. | $66.85 | 2019-2025 | Atriclip Laa Exclusion System |
| Xeris Pharmaceuticals, INC. | $59.73 | 2023-2025 | Keveyis |
| Akcea Therapeutics, INC. | $57.11 | 2020 | |
| United Therapeutics Corporation | $57.03 | 2020-2022 | |
| Cardinal Health 200 LLC | $52.00 | 2019 | |
| Ge Healthcare | $46.27 | 2020 | |
| Stryker Corporation | $44.03 | 2025 | Clottriever Bold Catheter |
| Inspire Medical Systems, INC. | $43.30 | 2025 | Inspire |
| Lexicon Pharmaceuticals, INC. | $34.66 | 2023 | Inpefa |
| Daiichi Sankyo INC. | $33.00 | 2020 | |
| Arbor Pharmaceuticals, INC. | $32.24 | 2019 | |
| Glaxosmithkline, LLC. | $23.92 | 2025 | Shingrix, Arexvy |
| Abiomed | $22.47 | 2020 | |
| Bardy Diagnostics, INC. | $22.00 | 2019-2020 | |
| Cvrx, INC. | $15.88 | 2022 | |
| Reflow Medical INC | $15.59 | 2024 | |
| Aegerion Pharmaceuticals, INC. | $15.11 | 2019 | |
| Innovation Technologies INC | $14.58 | 2025 | Irrisept |
| Cardiovascular Systems INC. | $14.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Rieder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.